Company News in the Life Science Industry

»

Reset 

BioAmber Announces New Chief Executive Officer

MONTREAL, Sept. 14, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) (TSX: BIOA)

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  BioAmber Inc.

Patient-Driven Dose Titration with Sanofi's Toujeo Improved Blood Glucose Control Without Increasing Hypoglycemia Risk in Real-Life Clinical Practice

LISBON, Portugal, Sept. 14, 2017 /PRNewswire/ -- A new randomized clinical trial, TAKE CONTROL(1), demonstrated better control of blood sugar (HbA(1c)) without increasing the risk of hypoglycemia in people with type 2 diabetes (T2D) by using Toujeo(®) (insulin glargine 300 Units/mL, Gla-300)... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Sanofi S.A.

CSL Behring Joins Together With Conference Attendees to Make Donation to IPOPI

EDINBURGH, United Kingdom, Sept. 14, 2017 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that its "Join Together" campaign at the 2017 European Society for Immunodeficiencies (Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Bayer and Ginkgo Bioworks join forces for sustainable agriculture, forming new company with USD 100 million Series A

LEVERKUSEN, Germany and BOSTON, Sept. 14, 2017 /PRNewswire/ -- Bayer and Ginkgo Bioworks will create a new company focused on the plant microbiome. Improving the microbes' ability to make nitrogen fertilizer available for plants offers a major potential benefit to sustainable agriculture. The... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Bayer AG | Bayer Gemüse- und Fruchtsaft GmbH

Surfacer® Inside-Out® Access Catheter System to be Showcased at CIRSE 2017 Annual Meeting

SAN ANTONIO, Sept. 14, 2017 /PRNewswire/ -- Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced its upcoming Surfacer®... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

DIAsource ImmunoAssays SA Acquired Viro-Immun Diagnostics GmbH

LOUVAIN-LA-NEUVE, Belgium, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

INAAT Market Size to Reach $4.3 Billion by 2025 | CAGR: 11.8%: Grand View Research, Inc.

SAN FRANCISCO, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Eyebrow enhancement company to donate 10% of proceeds to Look Good Feel Better® during October's Breast Cancer Awareness Month

AUBURN HILLS, Mich., Sept. 14, 2017 /PRNewswire/ -- EES-Essential Eyebrow Solution®, the only clinically-tested cosmetic eyebrow product on the market proven to help combat eyebrow thinning, was originally formulated... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Breakfast Technical Briefing on Health Care Plans Stocks -- CVS Health, Humana, Molina Healthcare, and UnitedHealth

NEW YORK, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Molina Healthcare, Inc. | Humana Inc. | UnitedHealth Group

Surgical Drainage Devices Market Size Worth $2.3 Billion by 2025: Grand View Research, Inc.

SAN FRANCISCO, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Quest Diagnostics Sustainability Efforts Earn Place on DJSI World Index for Fourteenth Consecutive Year

MADISON, N.J., Sept. 14, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, was named for the thirteenth consecutive year in the North America Dow Jones... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Quest Diagnostics, Inc.

Stocks Under Scanner in the Biotech Space -- Puma Biotech, Regeneron Pharma, Sarepta Therapeutics, and Seattle Genetics

NEW YORK, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Regeneron Pharmaceuticals, Inc. | Sarepta Therapeutics | Seattle Genetics, Inc.

Technical Insights on Medical Equipment Wholesale Stocks -- Henry Schein, Patterson, Owens & Minor, and PharMerica

NEW YORK, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Henry Schein Inc. | Patterson Companies, Inc.

ChemicalInfo Announces Enhancements to Help Subscribers Identify Producers

DALLAS, Sept. 14, 2017 /PRNewswire/ -- ChemicalInfo, providers of the most comprehensive online databases for chemical and pharmaceutical companies and those who do business with them, announces significant improvements to data within its Directory of World Chemical Producers (DWCP) in 2017.... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

Oncolytics Biotech® Announces First Patient Treated in MUK eleven Study

CALGARY and SAN DIEGO, Sept. 14, 2017 /PRNewswire/ - Oncolytics Biotech(®) Inc. (TSX: ONC) (OTCQX: ONCYF) (Oncolytics or the Company), a biotech company developing REOLYSIN(®) (pelareorep), a first-in-class, systemically delivered immuno-oncolytic virus that activates the innate and adaptive... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Western Oncolytics

Kaiser Permanente and Target to Open 31 More Retail Clinics in Southern California

PASADENA, Calif., Sept. 14, 2017 /PRNewswire/ -- Kaiser Permanente, the nation's largest integrated health system, and Target Corporation (NYSE: TGT) announced they will launch 31 additional Kaiser Permanente-staffed retail clinics in Target stores across Southern California. Through this collaboration,... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

OWC Pharma Issues Chairman's Letter to Shareholders

PETACH TIKVA, Israel, September 14, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Halozyme Licenses New Enhanze Target For $30 Million Upfront Payment, Future Milestones And Royalties

SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today it licensed its ENHANZE(®) drug-delivery technology to Roche for exclusive development of an undisclosed therapeutic target.

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Halozyme Therapeutics, Inc.

Halozyme Increases 2017 Financial Guidance

SAN DIEGO, Sept. 14, 2017 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today raised financial guidance for 2017 following the announcement of two new licensing agreements for its ENHANZE(®) drug-delivery... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Halozyme Therapeutics, Inc.

Trillium Therapeutics to Present at Investor and Scientific Conferences in September

NASDAQ: TRIL
TSX: TRIL

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Trillium Technologies Group Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 23  24  25 »

Explore our database of over 40,000 companies